| 5001 | OTUD6B levels | GCST90470136 | 1.48 |
| 5002 | Unspecified acute lower respiratory infection | FING00001398 | 1.48 |
| 5003 | ALB levels | GCST90497101 | 1.48 |
| 5004 | IDP dMRI TBSS ICVF Genu of corpus callosum | GCST90004329 | 1.48 |
| 5005 | STK11/USP8 ratio | GCST90315892 | 1.48 |
| 5006 | ATOX1 levels | GCST90468385 | 1.48 |
| 5007 | CHCHD10 levels | GCST90468738 | 1.48 |
| 5008 | T1 CAT volume R CrusI | GCST90384120 | 1.48 |
| 5009 | CD79B levels | GCST90468648 | 1.48 |
| 5010 | SERPINE1 levels | GCST90470596 | 1.48 |
| 5011 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T130 | ECGU000130 | 1.48 |
| 5012 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T45 | ECGA000045 | 1.47 |
| 5013 | DAG1/SCARF1 ratio | GCST90314381 | 1.47 |
| 5014 | Pure hyperglyceridaemia | FING00001231 | 1.47 |
| 5015 | BCL2L1 levels | GCST90468432 | 1.47 |
| 5016 | IGFBP4/OGN ratio | GCST90315134 | 1.47 |
| 5017 | Principal component-derived dietary pattern 27 | GCST90133032 | 1.47 |
| 5018 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T179 | ECGA000179 | 1.47 |
| 5019 | aparc-pial rh area precentral | GCST90003197 | 1.47 |
| 5020 | NT5C3A levels | GCST90470091 | 1.47 |
| 5021 | CXCL11/VTA1 ratio | GCST90314337 | 1.47 |
| 5022 | WIF1 levels | GCST90471078 | 1.47 |
| 5023 | X-12038 levels | GCST90243683 | 1.47 |
| 5024 | ABHD14B levels | GCST90468189 | 1.46 |
| 5025 | Coronary artery bypass grafting | FING00000358 | 1.46 |
| 5026 | ADAM23 levels | GCST90240922 | 1.46 |
| 5027 | SPINK6 levels | GCST90470725 | 1.46 |
| 5028 | YBX1 levels | GCST90090799 | 1.46 |
| 5029 | EPPK1 levels | GCST90469137 | 1.46 |
| 5030 | DSC2 levels | GCST90469040 | 1.46 |
| 5031 | DLL1/NECTIN4 ratio | GCST90314497 | 1.46 |
| 5032 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T178 | ECGA000178 | 1.46 |
| 5033 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T310 | ECGU000310 | 1.46 |
| 5034 | CPA1/PLA2G1B ratio | GCST90314205 | 1.46 |
| 5035 | aseg rh volume Putamen | GCST90002639 | 1.45 |
| 5036 | IPCEF1/TBCC ratio | GCST90315188 | 1.45 |
| 5037 | IDP T1 SIENAX brain-unnormalised volume | GCST90002435 | 1.45 |
| 5038 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T183 | ECGA000183 | 1.45 |
| 5039 | LDL direct, adjusted by medication | Lipid or lipoprotein measurement | UKBB00000388 | 1.45 |
| 5040 | Congenital lactase deficiency | FING00000329 | 1.45 |
| 5041 | IDP dMRI TBSS L2 Posterior thalamic radiation R | GCST90004151 | 1.45 |
| 5042 | DTI TBSS L1 Anterior corona radiata L | GCST90384451 | 1.45 |
| 5043 | FUT8/SORT1 ratio | GCST90314892 | 1.44 |
| 5044 | RGMB/TNFRSF21 ratio | GCST90315772 | 1.44 |
| 5045 | X-12095--N1-methyl-3-pyridone-4-carboxamide levels | GCST90243701 | 1.44 |
| 5046 | aparc-a2009s rh thickness G-postcentral | GCST90003704 | 1.44 |
| 5047 | Age-related eyesight deterioration (confirmatory factor analysis Factor 27) | GCST90309361 | 1.44 |
| 5048 | IDP dMRI TBSS L1 Sagittal stratum L | GCST90004106 | 1.44 |
| 5049 | Daytime dozing / sleeping (narcolepsy) | Sleep | UKBB00000164 | 1.44 |
| 5050 | Takes medication for high cholesterol? | GCST90475208 | 1.44 |
| 5051 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T386 | ECGU000386 | 1.44 |
| 5052 | wg rh intensity-contrast parsorbitalis | GCST90003845 | 1.44 |
| 5053 | Other disorders of breast | FING00001018 | 1.44 |
| 5054 | PADI4 levels | GCST90470143 | 1.44 |
| 5055 | aparc-Desikan rh area precentral | GCST90003130 | 1.44 |
| 5056 | mean corpuscular hemoglobin concentration (MCHC, minimum, inv-norm transformed) | GCST90475460 | 1.44 |
| 5057 | aseg lh volume Accumbens-area | GCST90002626 | 1.44 |
| 5058 | TRAF2/WWP2 ratio | GCST90315943 | 1.44 |
| 5059 | COL6A3 levels | GCST90468821 | 1.44 |
| 5060 | ERBB4/UMOD ratio | GCST90314692 | 1.44 |
| 5061 | HSBP1 levels | GCST90469481 | 1.44 |
| 5062 | Diacylglycerol_34:0_[M+H-H2O]1+ levels | GCST90060181 | 1.43 |
| 5063 | CACNB3 levels | GCST90468523 | 1.43 |
| 5064 | CD72 levels | GCST90468646 | 1.43 |
| 5065 | CTSZ/SMPDL3A ratio | GCST90314322 | 1.43 |
| 5066 | hemoglobin (minimum, inv-norm transformed) | GCST90475380 | 1.43 |
| 5067 | T1 CAT volume L LeftPutamen | GCST90384100 | 1.43 |
| 5068 | LBR levels | GCST90469744 | 1.43 |
| 5069 | Operation code - hysterectomy | Operations | UKBB00000559 | 1.43 |
| 5070 | HippSubfield lh volume GC-ML-DG-body | GCST90002681 | 1.43 |
| 5071 | T1 FreeSurfer aseg Left-Putamen | GCST90384145 | 1.43 |
| 5072 | Umbilical hernia | Hernia | UKBB00000881 | 1.43 |
| 5073 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T292 | ECGA000292 | 1.42 |
| 5074 | aparc-a2009s lh volume G-postcentral | GCST90002952 | 1.42 |
| 5075 | RGS10 levels | GCST90470465 | 1.42 |
| 5076 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T239 | ECGA000239 | 1.42 |
| 5077 | Total lipid levels in large LDL | GCST90092862 | 1.42 |
| 5078 | Urate levels | GCST001791 | 1.42 |
| 5079 | Principal component-derived dietary pattern 18 | GCST90133023 | 1.42 |
| 5080 | Mean reticulocyte volume | GCST90025975 | 1.42 |
| 5081 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T242 | ECGA000242 | 1.42 |
| 5082 | YWHAQ levels | GCST90471092 | 1.42 |
| 5083 | DEFA1_DEFA1B/LCN2 ratio | GCST90314454 | 1.42 |
| 5084 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T113 | ECGA000113 | 1.42 |
| 5085 | MINK1 levels | GCST90469909 | 1.41 |
| 5086 | Leg fat percentage (right) | Impedance measures | UKBB00000392 | 1.41 |
| 5087 | MFAP5 levels | GCST90469899 | 1.41 |
| 5088 | HBEGF/WWP2 ratio | GCST90315038 | 1.41 |
| 5089 | AXL/MSR1 ratio | GCST90313422 | 1.41 |
| 5090 | Mean corpuscular haemoglobin | Blood count | UKBB00000447 | 1.41 |
| 5091 | BA-exvivo lh area BA4p | GCST90003212 | 1.41 |
| 5092 | Triglyceride (52:5) levels | GCST90488320 | 1.41 |
| 5093 | CPA4 levels | GCST90468838 | 1.41 |
| 5094 | Brainstem global volume Midbrain | GCST90002767 | 1.41 |
| 5095 | CCL8 levels | GCST90422346 | 1.41 |
| 5096 | CLEC14A levels | GCST90468766 | 1.41 |
| 5097 | CD209/ITGAV ratio | GCST90313753 | 1.41 |
| 5098 | CLEC4G/KDR ratio | GCST90314118 | 1.40 |
| 5099 | Cholesteryl Esters in LDL | GCST90498374 | 1.40 |
| 5100 | DNAJA2 levels | GCST90469009 | 1.40 |
| 5101 | IDP dMRI TBSS ICVF Anterior limb of internal capsule R | GCST90004343 | 1.40 |
| 5102 | Recent feelings of inadequacy | Depression | UKBB00000739 | 1.40 |
| 5103 | Percent liver fat | GCST90016673 | 1.40 |
| 5104 | CNPY4/MESD ratio | GCST90314152 | 1.40 |
| 5105 | T1 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 82) | GCST90320645 | 1.40 |
| 5106 | Remnant cholesterol (non-HDL, non-LDL -cholesterol) | GCST90499340 | 1.40 |
| 5107 | aparc-a2009s rh volume Pole-occipital | GCST90003040 | 1.40 |
| 5108 | IDP dMRI ProbtrackX MD ilf r | GCST90004234 | 1.40 |
| 5109 | Venous thromboembolism | FING00001427 | 1.40 |
| 5110 | EHBP1 levels | GCST90469088 | 1.39 |
| 5111 | Peripheral vascular disease | GCST90086134 | 1.39 |
| 5112 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T464 | ECGU000464 | 1.39 |
| 5113 | Mother's age | Family history | UKBB00000484 | 1.39 |
| 5114 | IDP dMRI TBSS MD Sagittal stratum R | GCST90004057 | 1.39 |
| 5115 | IDP dMRI TBSS OD Cerebral peduncle R | GCST90004416 | 1.39 |
| 5116 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T93 | ECGU000093 | 1.39 |
| 5117 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T194 | ECGU000194 | 1.39 |
| 5118 | ADGRG2/SDC1 ratio | GCST90313187 | 1.38 |
| 5119 | TNFRSF4 levels | GCST90470913 | 1.38 |
| 5120 | SNX15 levels | GCST90470699 | 1.38 |
| 5121 | NELL1 levels | GCST90242481 | 1.38 |
| 5122 | CST3/RARRES2 ratio | GCST90314295 | 1.38 |
| 5123 | T1 FreeSurfer aseg 4th-Ventricle | GCST90384148 | 1.38 |
| 5124 | CEP20 levels | GCST90468712 | 1.38 |
| 5125 | CA13/QDPR ratio | GCST90313564 | 1.38 |
| 5126 | Smoking status - Current | Smoking | UKBB00000779 | 1.38 |
| 5127 | SLC9A3R1 levels | GCST90470665 | 1.38 |
| 5128 | Pain (PheCode 338) | GCST90475836 | 1.38 |
| 5129 | Pulmonary embolism | GCST90468148 | 1.38 |
| 5130 | Minimum carotid IMT (intima-medial thickness) at 210 degrees | Carotid ultrasound | UKBB00000477 | 1.38 |
| 5131 | aseg lh volume Hippocampus | GCST90002624 | 1.38 |
| 5132 | Lichen simplex chronicus and prurigo | FING00000725 | 1.38 |
| 5133 | Liver volume | GCST90566818 | 1.37 |
| 5134 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T113 | ECGU000113 | 1.37 |
| 5135 | MANSC1/PODXL ratio | GCST90315372 | 1.37 |
| 5136 | Left-hemisphere salience/ventral attention network to amygdala white-matter structural connectivity | GCST90302724 | 1.37 |
| 5137 | IDP dMRI ProbtrackX MD str l | GCST90004242 | 1.37 |
| 5138 | Nonrheumatic aortic valve disorders (PheCode 395.2) | GCST90475914 | 1.37 |
| 5139 | CLEC14A/PIK3IP1 ratio | GCST90314080 | 1.37 |
| 5140 | DTI TBSS L1 Splenium of corpus callosum | GCST90384432 | 1.37 |
| 5141 | JPT2 levels | GCST90469663 | 1.37 |
| 5142 | Aspartate aminotransferase levels | GCST90278618 | 1.37 |
| 5143 | Triacylglycerol_48:3_[M+NH4]1+ levels | GCST90060418 | 1.37 |
| 5144 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T355 | ECGU000355 | 1.37 |
| 5145 | Cholesterol levels (UKB data field 30690) | GCST90468066 | 1.37 |
| 5146 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T452 | ECGU000452 | 1.37 |
| 5147 | CXCL5/SERPINE1 ratio | GCST90314354 | 1.37 |
| 5148 | ThalamNuclei rh volume PuI | GCST90002738 | 1.36 |
| 5149 | Chronic ischaemic heart disease | Ischaemic heart diseases | UKBB00000137 | 1.36 |
| 5150 | BA-exvivo lh area BA3a | GCST90003209 | 1.36 |
| 5151 | Skin red/green component | GCST90320258 | 1.36 |
| 5152 | USP25 levels | GCST90471019 | 1.36 |
| 5153 | Total free cholesterol levels (UKB data field 23419) | GCST90269516 | 1.36 |
| 5154 | HPCAL1 levels | GCST90469471 | 1.36 |
| 5155 | Hematocrit | GCST90002383 | 1.36 |
| 5156 | Pustulosis palmaris et plantaris | FING00001233 | 1.36 |
| 5157 | CETN2/TDRKH ratio | GCST90314031 | 1.36 |
| 5158 | BAG6/BMP6 ratio | GCST90313450 | 1.36 |
| 5159 | BCAN levels | GCST90468426 | 1.36 |
| 5160 | Total Lipids in LDL | GCST90498396 | 1.36 |
| 5161 | Corneal resistance factor | GCST90308682 | 1.36 |
| 5162 | Retinal detachments and breaks | Disorders of choroid and retina | UKBB00000755 | 1.36 |
| 5163 | mean corpuscular hemoglobin (MCH, maximum, inv-norm transformed) | GCST90475442 | 1.36 |
| 5164 | Serum phosphate levels | GCST90025948 | 1.35 |
| 5165 | IDP dMRI TBSS L2 External capsule L | GCST90004156 | 1.35 |
| 5166 | PILRB levels | GCST90470237 | 1.35 |
| 5167 | SCAMP3 levels | GCST90470532 | 1.35 |
| 5168 | MAP4K5 levels | GCST90469855 | 1.35 |
| 5169 | Percentage of fucosylation of monogalactosylated structures (with bisecting GlcNAc) in total neutral plasma glycans (GP82) | GCST90668526 | 1.35 |
| 5170 | Hearing difficulty/problems | Hearing | UKBB00000310 | 1.35 |
| 5171 | PCYT2 levels | GCST90470178 | 1.35 |
| 5172 | TNR levels | GCST90470929 | 1.35 |
| 5173 | hemoglobin (mean, inv-norm transformed) | GCST90475376 | 1.35 |
| 5174 | Right-hemisphere salience/ventral attention network to thalamus white-matter structural connectivity | GCST90302817 | 1.35 |
| 5175 | Treatment/medication code - allopurinol | Medications | UKBB00000839 | 1.35 |
| 5176 | IMPA1/TBCC ratio | GCST90315175 | 1.35 |
| 5177 | KLK6 levels | GCST90469705 | 1.35 |
| 5178 | Saturated fatty acids levels | GCST90502675 | 1.35 |
| 5179 | NELL2/SEZ6L ratio | GCST90315536 | 1.35 |
| 5180 | EPHB4 levels | GCST90469132 | 1.35 |
| 5181 | APP/NID2 ratio | GCST90313327 | 1.35 |
| 5182 | Temporomandibular joint disorders, including avohilmo | FING00001355 | 1.35 |
| 5183 | CLEC1B/VTA1 ratio | GCST90314107 | 1.35 |
| 5184 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T378 | ECGU000378 | 1.35 |
| 5185 | KLK8 levels | GCST90422316 | 1.34 |
| 5186 | Activities undertaken to treat anxiety | Anxiety | UKBB00000009 | 1.34 |
| 5187 | COL1A1/SOST ratio | GCST90314172 | 1.34 |
| 5188 | IDP dMRI TBSS FA Superior fronto-occipital fasciculus R | GCST90003919 | 1.34 |
| 5189 | Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified | FING00000432 | 1.34 |
| 5190 | Haemoglobin concentration (UKB data field 30020) | GCST90468074 | 1.34 |
| 5191 | DNM1 levels | GCST90469021 | 1.34 |
| 5192 | DTI TBSS MD Fornix cres+Stria terminalis R | GCST90384610 | 1.34 |
| 5193 | Benign neoplasm: Parotid gland | FING00000192 | 1.34 |
| 5194 | Bone marrow fat fraction of lumbar vertebra 1 | GCST90652386 | 1.34 |
| 5195 | PPP1R2/TBL1X ratio | GCST90315720 | 1.34 |
| 5196 | IDP dMRI ProbtrackX L3 cgc r | GCST90004305 | 1.34 |
| 5197 | MITD1/SNX9 ratio | GCST90315454 | 1.34 |
| 5198 | MEGF9/MET ratio | GCST90315418 | 1.34 |
| 5199 | FABP6 levels | GCST90469178 | 1.34 |
| 5200 | Mean corpuscular hemoglobin concentration | GCST90002329 | 1.34 |
| 5201 | TSC22D1 levels | GCST90470973 | 1.34 |
| 5202 | MOG levels | GCST90469929 | 1.34 |
| 5203 | Dermatophytosis (PheCode 110.1) | GCST90475561 | 1.34 |
| 5204 | Severe, life-threatening illness (confirmatory factor analysis Factor 20) | GCST90309354 | 1.34 |
| 5205 | CALCOCO1/METAP2 ratio | GCST90313606 | 1.33 |
| 5206 | CLMP/GFRA1 ratio | GCST90314133 | 1.33 |
| 5207 | NRCAM levels | GCST90470082 | 1.33 |
| 5208 | IL18 levels | GCST90469567 | 1.33 |
| 5209 | CCL11 levels | GCST90468564 | 1.33 |
| 5210 | LRRFIP1 levels | GCST90469805 | 1.33 |
| 5211 | DDR1 levels | GCST90468970 | 1.33 |
| 5212 | Ulcerative ileocolitis | FING00001392 | 1.33 |
| 5213 | Angina pectoris | FING00000086 | 1.33 |
| 5214 | T2 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 22) | GCST90320841 | 1.33 |
| 5215 | PLSCR3 levels | GCST90470261 | 1.33 |
| 5216 | BMP10 levels | GCST90468452 | 1.32 |
| 5217 | aparc-DKTatlas lh volume parsopercularis | GCST90002878 | 1.32 |
| 5218 | DTI autoptx L2 cgc r tract | GCST90385171 | 1.32 |
| 5219 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T306 | ECGU000306 | 1.32 |
| 5220 | Type 1 diabetes with ophthalmic manifestations (PheCode 250.13) | GCST90475663 | 1.32 |
| 5221 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T80 | ECGA000080 | 1.32 |
| 5222 | wg lh intensity-contrast temporalpole | GCST90003824 | 1.32 |
| 5223 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T75 | ECGA000075 | 1.32 |
| 5224 | Lymphoplasmacytic lymphoma and Waldenstrom macroglobulinemia | GCST90624744 | 1.32 |
| 5225 | IDP dMRI TBSS L2 Superior corona radiata R | GCST90004147 | 1.32 |
| 5226 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T313 | ECGU000313 | 1.32 |
| 5227 | PPP1R12A/TXNDC5 ratio | GCST90315714 | 1.32 |
| 5228 | Diffuse idiopathic skeletal hyperostosis flow score | GCST90134532 | 1.31 |
| 5229 | Bell's palsy | FING00000144 | 1.31 |
| 5230 | ECHS1 levels | GCST90469063 | 1.31 |
| 5231 | Nontoxic diffuse goitre | FING00000886 | 1.31 |
| 5232 | ARHGAP1 levels | GCST90468352 | 1.31 |
| 5233 | Reticulocyte percentage | Blood count | UKBB00000753 | 1.31 |
| 5234 | Savoury biscuit liking | GCST90094834 | 1.31 |
| 5235 | aparc-Desikan lh area TotalSurface | GCST90003073 | 1.31 |
| 5236 | F2R/TMSB10 ratio | GCST90314738 | 1.31 |
| 5237 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T243 | ECGA000243 | 1.30 |
| 5238 | THBS4 levels | GCST90470855 | 1.30 |
| 5239 | Types of physical activity in last 4 weeks - Strenuous sports | Physical activity | UKBB00000874 | 1.30 |
| 5240 | REG4/SPINK4 ratio | GCST90315766 | 1.30 |
| 5241 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T244 | ECGA000244 | 1.30 |
| 5242 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T106 | ECGA000106 | 1.30 |
| 5243 | GFER levels | GCST90469326 | 1.30 |
| 5244 | DVT of lower extremities | FING00000482 | 1.30 |
| 5245 | BTN2A1/LILRB4 ratio | GCST90313546 | 1.30 |
| 5246 | Non-small cell lung cancer, squamous, excluding all cancers (controls excluding all cancers) | FING00000877 | 1.29 |
| 5247 | Daytime nap | GCST011494 | 1.29 |
| 5248 | Bread type: White vs wholemeal/wholegrain and brown (UKB data field 1448) | GCST90132967 | 1.29 |
| 5249 | Attendance/disability/mobility allowance - Disability living allowance | Other sociodemographic factors | UKBB00000058 | 1.29 |
| 5250 | ICD10 N80: Endometriosis | GCST90454213 | 1.29 |
| 5251 | End-diastolic bi-ventricular shape (principal component 9) | GCST90448488 | 1.29 |
| 5252 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T173 | ECGU000173 | 1.29 |
| 5253 | Neuroticism | GCST003770 | 1.29 |
| 5254 | red cell diameter width (RDW, maximum, inv-norm transformed) | GCST90476355 | 1.29 |
| 5255 | Pyruvate levels (UKB data field 23472) | GCST90269569 | 1.29 |
| 5256 | CIRBP levels | GCST90468756 | 1.29 |
| 5257 | Belittlement by partner or ex-partner as an adult | Traumatic events | UKBB00000091 | 1.29 |
| 5258 | Lysoalkylphosphatidylcholine (O-20:0) levels | GCST90025432 | 1.29 |
| 5259 | IDP dMRI TBSS MD Superior cerebellar peduncle R | GCST90004039 | 1.29 |
| 5260 | CILP levels | GCST90468754 | 1.28 |
| 5261 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T257 | ECGU000257 | 1.28 |
| 5262 | Any mental disorder | FING00000100 | 1.28 |
| 5263 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T117 | ECGA000117 | 1.28 |
| 5264 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T463 | ECGU000463 | 1.28 |
| 5265 | Medication for pain relief, constipation, heartburn - Aspirin | Medication | UKBB00000454 | 1.28 |
| 5266 | Enlarged prostate (Benign prostatic hyperplasia) | GCST90475261 | 1.28 |
| 5267 | Plasma N-acetylhistidine levels in chronic kidney disease | GCST90265576 | 1.28 |
| 5268 | MYH9 levels | GCST90469975 | 1.28 |
| 5269 | CES1 levels | GCST90468718 | 1.28 |
| 5270 | DCXR/KYNU ratio | GCST90314438 | 1.28 |
| 5271 | IDP dMRI TBSS ICVF Fornix cres+Stria terminalis L | GCST90004366 | 1.28 |
| 5272 | CRYBB2 levels | GCST90468875 | 1.28 |
| 5273 | Leg fat percentage (left) | Impedance measures | UKBB00000391 | 1.28 |
| 5274 | Mean corpuscular volume | GCST90002392 | 1.28 |
| 5275 | LAMA4/PDGFB ratio | GCST90315273 | 1.28 |
| 5276 | 4-androsten-3beta,17beta-diol disulfate 1 levels | GCST90243879 | 1.27 |
| 5277 | LMOD1 levels | GCST90469783 | 1.27 |
| 5278 | Body mass index | GCST90018727 | 1.27 |
| 5279 | Mean corpuscular hemoglobin | GCST90002390 | 1.27 |
| 5280 | ATP5IF1/FIS1 ratio | GCST90313385 | 1.27 |
| 5281 | IDP dMRI TBSS L3 Inferior cerebellar peduncle R | GCST90004181 | 1.27 |
| 5282 | Spermatocele (PheCode 603.2) | GCST90476158 | 1.27 |
| 5283 | BLOC1S3 levels | GCST90468450 | 1.27 |
| 5284 | CCL25 levels | GCST90468577 | 1.27 |
| 5285 | Principal component-derived dietary pattern 46 | GCST90133051 | 1.27 |
| 5286 | Citrate levels (UKB data field 23473) | GCST90269570 | 1.27 |
| 5287 | IDP dMRI TBSS L1 Anterior corona radiata L | GCST90004098 | 1.27 |
| 5288 | DMP1 levels | GCST90469007 | 1.27 |
| 5289 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T446 | ECGU000446 | 1.27 |
| 5290 | IDP T1 FAST ROIs L ventral striatum | GCST90002559 | 1.27 |
| 5291 | mean corpuscular hemoglobin concentration (MCHC, minimum, inv-norm transformed) | GCST90475462 | 1.27 |
| 5292 | FLT1 levels | GCST90469249 | 1.27 |
| 5293 | Total body bone mineral density (age 0-15) | GCST005345 | 1.27 |
| 5294 | Types of physical activity in last 4 weeks - Other exercises (eg: swimming, cycling, keep fit, bowling) | Physical activity | UKBB00000873 | 1.27 |
| 5295 | Uterine fibroids | GCST90468154 | 1.27 |
| 5296 | Mean corpuscular volume | GCST90002335 | 1.26 |
| 5297 | Dementia, including avohilmo | FING00000395 | 1.26 |
| 5298 | Dermatophytosis of nail (PheCode 110.11) | GCST90475562 | 1.26 |
| 5299 | Height, inverse-rank normalized | FING00000607 | 1.26 |
| 5300 | IDP dMRI TBSS L1 Anterior corona radiata R | GCST90004097 | 1.26 |
| 5301 | Hallux valgus (Bunion) (PheCode 735.3) | GCST90476251 | 1.26 |
| 5302 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T118 | ECGA000118 | 1.26 |
| 5303 | Cholesteryl ester levels in medium VLDL | GCST90092918 | 1.26 |
| 5304 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T317 | ECGA000317 | 1.26 |
| 5305 | Low density lipoprotein cholesterol levels | GCST90002412 | 1.26 |
| 5306 | IDP dMRI TBSS L3 Cingulum cingulate gyrus L | GCST90004206 | 1.26 |
| 5307 | CSTB levels | GCST90012006 | 1.26 |
| 5308 | PON2/PON3 ratio | GCST90315703 | 1.26 |
| 5309 | KCNA10 levels | GCST90617893 | 1.26 |
| 5310 | Spread type: Butter/spreadable butter (UKB data field 1428_1) | GCST90132953 | 1.26 |
| 5311 | Omega-3 fatty acid levels | GCST90502423 | 1.26 |
| 5312 | Coronary angioplasty | FING00000357 | 1.26 |
| 5313 | IDP dMRI TBSS MO Cerebral peduncle L | GCST90003967 | 1.26 |
| 5314 | F3 levels | GCST90012014 | 1.26 |
| 5315 | Hearing difficulty/problems: Yes (UKB data field 2247_1) | GCST90042882 | 1.25 |
| 5316 | Platelet distribution width | Blood count | UKBB00000648 | 1.25 |
| 5317 | GORASP2 levels | GCST90469378 | 1.25 |
| 5318 | Urine X-24796 levels in chronic kidney disease | GCST90266800 | 1.25 |
| 5319 | 2-aminobutyrate levels | GCST90243584 | 1.25 |
| 5320 | IGSF3 levels | GCST90469539 | 1.25 |
| 5321 | Right-hemisphere somatomotor network to right-hemisphere control network white-matter structural connectivity | GCST90302792 | 1.25 |
| 5322 | ALB levels | GCST90092807 | 1.25 |
| 5323 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T94 | ECGA000094 | 1.25 |
| 5324 | Omega-3 fatty acids to Omega-6 fatty acids ratio | GCST90502397 | 1.25 |
| 5325 | Age at first birth | GCST90000048 | 1.25 |
| 5326 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T229 | ECGA000229 | 1.25 |
| 5327 | aparc-pial lh area parstriangularis | GCST90003160 | 1.25 |
| 5328 | Dyslipidemia | GCST90086077 | 1.25 |
| 5329 | C4BPB levels | GCST90468499 | 1.25 |
| 5330 | DNAJA2/PLXNA4 ratio | GCST90314504 | 1.25 |
| 5331 | PLAU levels | GCST90470252 | 1.25 |
| 5332 | Mixed conductive and sensorineural hearing loss | FING00000827 | 1.25 |
| 5333 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T243 | ECGU000243 | 1.25 |
| 5334 | IDP dMRI TBSS MD Cingulum cingulate gyrus R | GCST90004061 | 1.25 |
| 5335 | IDP dMRI TBSS ICVF Medial lemniscus R | GCST90004335 | 1.25 |
| 5336 | APOBR levels | GCST90468334 | 1.24 |
| 5337 | HippSubfield rh volume CA1-head | GCST90002696 | 1.24 |
| 5338 | AXL/MCAM ratio | GCST90313421 | 1.24 |
| 5339 | LTA/LTBR ratio | GCST90315336 | 1.24 |
| 5340 | ICAM4 levels | GCST90469501 | 1.24 |
| 5341 | aparc-a2009s lh area S-central | GCST90003341 | 1.24 |
| 5342 | VMO1 levels | GCST90471042 | 1.24 |
| 5343 | SNX18 levels | GCST90470700 | 1.24 |
| 5344 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T187 | ECGA000187 | 1.24 |
| 5345 | LDL cholesterol levels | GCST90498346 | 1.24 |
| 5346 | EGF levels | GCST90469086 | 1.24 |
| 5347 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T335 | ECGA000335 | 1.24 |
| 5348 | Benign lipomatous neoplasm | FING00000146 | 1.24 |
| 5349 | Hematocrit | GCST90002304 | 1.24 |
| 5350 | Low density lipoprotein cholesterol levels | GCST90278638 | 1.23 |
| 5351 | CRKL/MGLL ratio | GCST90314270 | 1.23 |
| 5352 | F11R levels | GCST90469164 | 1.23 |
| 5353 | Intra-ocular pressure, Goldmann-correlated (left) | Intraocular pressure | UKBB00000376 | 1.23 |
| 5354 | Autorefraction - 3mm strong meridian angle (right) | Eyesight | UKBB00000068 | 1.23 |
| 5355 | DTI autoptx FA ilf l tract | GCST90385126 | 1.23 |
| 5356 | Total cholesterol minus HDL-C levels | GCST90499129 | 1.23 |
| 5357 | IDP SWI T2star right putamen | GCST90003868 | 1.23 |
| 5358 | Left-hemisphere default mode network to right-hemisphere dorsal attention network white-matter structural connectivity | GCST90302762 | 1.23 |
| 5359 | Diacylglycerol_36:4_[M+H-H2O]1+ levels | GCST90060188 | 1.23 |
| 5360 | Total lipid levels in lipoprotein particles | GCST90500085 | 1.23 |
| 5361 | F-bitter food liking (derived food-liking factor) | GCST90094706 | 1.23 |
| 5362 | APP/LAMA4 ratio | GCST90313325 | 1.23 |
| 5363 | Red blood cell erythrocyte count (UKB data field 30010) | GCST90468098 | 1.22 |
| 5364 | Red blood cell count | GCST90002403 | 1.22 |
| 5365 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T319 | ECGA000319 | 1.22 |
| 5366 | Heart failure and bmi 25plus | FING00000603 | 1.22 |
| 5367 | Tea difference liking | GCST90094855 | 1.22 |
| 5368 | aseg rh volume Cerebellum-White-Matter | GCST90002635 | 1.22 |
| 5369 | Total cholesterol levels (UKB data field 23400) | GCST90269497 | 1.22 |
| 5370 | Total testosterone levels | GCST90239820 | 1.22 |
| 5371 | IFNAR1 levels | GCST90469512 | 1.22 |
| 5372 | Medication for pain relief, constipation, heartburn - None of the above | Medication | UKBB00000457 | 1.22 |
| 5373 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T184 | ECGA000184 | 1.22 |
| 5374 | Unspecified dementia | FING00001400 | 1.22 |
| 5375 | IDP dMRI TBSS L2 Posterior corona radiata L | GCST90004150 | 1.22 |
| 5376 | F9/RARRES2 ratio | GCST90314749 | 1.21 |
| 5377 | Monounsaturated fatty acids to total fatty acids percentage | GCST90502389 | 1.21 |
| 5378 | Nonalcoholic fatty liver disease | GCST90091033 | 1.21 |
| 5379 | IDP dMRI ProbtrackX ICVF slf r | GCST90004397 | 1.21 |
| 5380 | DTI TBSS L2 Anterior corona radiata R | GCST90384498 | 1.21 |
| 5381 | CA1/HMBS ratio | GCST90313573 | 1.21 |
| 5382 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T158 | ECGA000158 | 1.21 |
| 5383 | CRACR2A/DNMBP ratio | GCST90314226 | 1.21 |
| 5384 | Benign neoplasm: salivary glands, exclude unknown (D119) | FING00000199 | 1.21 |
| 5385 | MARS1 levels | GCST90469862 | 1.21 |
| 5386 | BIN2/PDLIM7 ratio | GCST90313509 | 1.20 |
| 5387 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T79 | ECGU000079 | 1.20 |
| 5388 | CPA1/CTRB1 ratio | GCST90314203 | 1.20 |
| 5389 | CR2/TNFRSF13B ratio | GCST90314225 | 1.20 |
| 5390 | TRIM25 levels | GCST90470966 | 1.20 |
| 5391 | DTI autoptx L1 ptr l tract | GCST90385158 | 1.20 |
| 5392 | ANG levels | GCST90468307 | 1.20 |
| 5393 | SEL1L levels | GCST90470564 | 1.20 |
| 5394 | Psoriatic arthropathies | FING00001225 | 1.20 |
| 5395 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T83 | ECGU000083 | 1.20 |
| 5396 | FKBP5/TBCC ratio | GCST90314849 | 1.20 |
| 5397 | HippSubfield lh volume presubiculum-head | GCST90002673 | 1.20 |
| 5398 | What is your height? (cm, inv-normal transformed) | GCST90475368 | 1.20 |
| 5399 | Sleep duration | GCST003839 | 1.20 |
| 5400 | CD58/TYRO3 ratio | GCST90313856 | 1.20 |
| 5401 | Right-hemisphere somatomotor network to putamen white-matter structural connectivity | GCST90302796 | 1.19 |
| 5402 | CWC15 levels | GCST90468920 | 1.19 |
| 5403 | IDP dMRI TBSS L3 Anterior corona radiata R | GCST90004193 | 1.19 |
| 5404 | Central pulse pressure | GCST90267387 | 1.19 |
| 5405 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T104 | ECGA000104 | 1.19 |
| 5406 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T287 | ECGA000287 | 1.19 |
| 5407 | DNMBP/TJAP1 ratio | GCST90314521 | 1.19 |
| 5408 | MATN3 levels | GCST90469865 | 1.19 |
| 5409 | KIAA0319 levels | GCST90469676 | 1.19 |
| 5410 | Common executive function | GCST90503115 | 1.19 |
| 5411 | Exophthalmic conditions | FING00000526 | 1.19 |
| 5412 | N-acetylcarnosine levels | GCST90199926 | 1.19 |
| 5413 | aparc-DKTatlas lh area caudalmiddlefrontal | GCST90003236 | 1.19 |
| 5414 | Ever thought that life not worth living | Self-harm behaviours | UKBB00000225 | 1.19 |
| 5415 | aparc-DKTatlas rh area precentral | GCST90003287 | 1.19 |
| 5416 | Idiopathic gout | FING00000658 | 1.18 |
| 5417 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T103 | ECGU000103 | 1.18 |
| 5418 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T114 | ECGA000114 | 1.18 |
| 5419 | IGSF8/VSIR ratio | GCST90315141 | 1.18 |
| 5420 | VGF levels | GCST90471038 | 1.18 |
| 5421 | IDP dMRI ProbtrackX ICVF ar r | GCST90004376 | 1.18 |
| 5422 | MEPE levels | GCST90469889 | 1.18 |
| 5423 | RARRES2/TFPI ratio | GCST90315760 | 1.18 |
| 5424 | T1 FreeSurfer DK rh lateraloccipital area | GCST90385699 | 1.18 |
| 5425 | VASN levels | GCST90471027 | 1.18 |
| 5426 | Liver liking | GCST90094794 | 1.18 |
| 5427 | Carnitine levels | GCST90199621 | 1.18 |
| 5428 | CRADD/SIRT2 ratio | GCST90314243 | 1.18 |
| 5429 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T302 | ECGA000302 | 1.18 |
| 5430 | PLA2G4A/SNX9 ratio | GCST90315670 | 1.17 |
| 5431 | GLB1/IMPA1 ratio | GCST90314932 | 1.17 |
| 5432 | X-21471 levels | GCST90200586 | 1.17 |
| 5433 | IDP T1 FAST ROIs R ventral striatum | GCST90002560 | 1.17 |
| 5434 | PDGFB/UXS1 ratio | GCST90315634 | 1.17 |
| 5435 | IDP dMRI ProbtrackX L3 atr l | GCST90004302 | 1.17 |
| 5436 | ITGAM levels | GCST90469638 | 1.17 |
| 5437 | GSTA1/PBLD ratio | GCST90314994 | 1.17 |
| 5438 | CCL17/CD69 ratio | GCST90313684 | 1.17 |
| 5439 | CRTAM/GZMA ratio | GCST90314275 | 1.17 |
| 5440 | LY6D levels | GCST90469821 | 1.17 |
| 5441 | Body mass index (UKB data field 21001) | GCST90468161 | 1.17 |
| 5442 | Human herpes virus 7 U14 antibody levels | GCST90006909 | 1.17 |
| 5443 | CD58/SIRPB1 ratio | GCST90313855 | 1.16 |
| 5444 | Medication use (beta blocking agents) | GCST90018766 | 1.16 |
| 5445 | TIMP3/ZBTB16 ratio | GCST90315921 | 1.16 |
| 5446 | Avocado liking | GCST90094694 | 1.16 |
| 5447 | Retinal detachments and defects | sense organs | UKBB00000756 | 1.16 |
| 5448 | DTI TBSS MD Splenium of corpus callosum | GCST90384576 | 1.16 |
| 5449 | aseg lh volume Putamen | GCST90002622 | 1.16 |
| 5450 | aparc-Desikan lh area caudalmiddlefrontal | GCST90003076 | 1.16 |
| 5451 | DPT levels | GCST90469036 | 1.16 |
| 5452 | Total cholesterol levels | GCST90500015 | 1.16 |
| 5453 | DNA methylation GrimAge acceleration | GCST90014288 | 1.16 |
| 5454 | Omega-6 fatty acids levels (UKB data field 23445) | GCST90269542 | 1.16 |
| 5455 | NMI levels | GCST90470056 | 1.16 |
| 5456 | CA3/HMBS ratio | GCST90313584 | 1.16 |
| 5457 | CRACR2A/LBR ratio | GCST90314228 | 1.16 |
| 5458 | CCN4 levels | GCST90468590 | 1.16 |
| 5459 | Bone marrow fat fraction of thoracic vertebra 9 | GCST90652381 | 1.15 |
| 5460 | COQ7 levels | GCST90468831 | 1.15 |
| 5461 | YARS1 levels | GCST90471087 | 1.15 |
| 5462 | Lysoalkylphosphatidylcholine (O-22:1) levels | GCST90024196 | 1.15 |
| 5463 | KIAA0040 levels | GCST90422552 | 1.15 |
| 5464 | Urine N-acetyl-cadaverine levels in chronic kidney disease | GCST90265541 | 1.15 |
| 5465 | IDP dMRI TBSS FA Body of corpus callosum | GCST90003880 | 1.15 |
| 5466 | LZTFL1 levels | GCST90469834 | 1.15 |
| 5467 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T320 | ECGA000320 | 1.15 |
| 5468 | HSPB1 levels | GCST90179317 | 1.15 |
| 5469 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T186 | ECGA000186 | 1.15 |
| 5470 | CYB5R2 levels | GCST90468937 | 1.15 |
| 5471 | CD300LG/TNFRSF1A ratio | GCST90313803 | 1.15 |
| 5472 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T314 | ECGU000314 | 1.15 |
| 5473 | Deep endometriosis | FING00000382 | 1.14 |
| 5474 | Average total household income before tax | Household | UKBB00000081 | 1.14 |
| 5475 | Rheumatoid arthritis | musculoskeletal | UKBB00000757 | 1.14 |
| 5476 | Left-hemisphere control network to right-hemisphere dorsal attention network white-matter structural connectivity | GCST90302747 | 1.14 |
| 5477 | FHIT/PARK7 ratio | GCST90314821 | 1.14 |
| 5478 | Ceramide (d18:2/24:1) levels | GCST90024684 | 1.14 |
| 5479 | BRAP levels | GCST90468464 | 1.14 |
| 5480 | aparc-a2009s lh thickness Pole-occipital | GCST90003644 | 1.14 |
| 5481 | NPPB levels | GCST90470074 | 1.14 |
| 5482 | CD164/CD99 ratio | GCST90313740 | 1.14 |
| 5483 | Alanine transaminase (ALT, mean, inv-norm transformed) | GCST90475112 | 1.14 |
| 5484 | ADAMTSL2 levels | GCST90468228 | 1.14 |
| 5485 | IGSF21 levels | GCST90469538 | 1.14 |
| 5486 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T301 | ECGA000301 | 1.14 |
| 5487 | MMP10 levels | GCST90469915 | 1.13 |
| 5488 | ABHD14B/APRT ratio | GCST90313137 | 1.13 |
| 5489 | X-13548 levels | GCST90243821 | 1.13 |
| 5490 | MYOM2 levels | GCST90469985 | 1.13 |
| 5491 | 5alpha-androstan-3beta,17beta-diol monosulfate (2) levels | GCST90199855 | 1.13 |
| 5492 | CAMKK1/FOXO1 ratio | GCST90313613 | 1.13 |
| 5493 | IDP T1 FAST ROIs L postcent gyrus | GCST90002483 | 1.13 |
| 5494 | Inguinal hernia | Hernia | UKBB00000363 | 1.13 |
| 5495 | Degree of unsaturation | GCST90502753 | 1.13 |
| 5496 | MAPKAPK2 levels | GCST90469858 | 1.13 |
| 5497 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T334 | ECGA000334 | 1.13 |
| 5498 | Takes medication for Diabetes/sugar? | GCST90475268 | 1.13 |
| 5499 | IDP dMRI TBSS MD Superior corona radiata L | GCST90004052 | 1.13 |
| 5500 | Other degenerative diseases of the nervous system | FING00000994 | 1.13 |
| 5501 | FGFR4 levels | GCST90469234 | 1.13 |
| 5502 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T84 | ECGU000084 | 1.13 |
| 5503 | Impedance of arm (right) | Impedance measures | UKBB00000357 | 1.13 |
| 5504 | MAP3K5/MAVS ratio | GCST90315379 | 1.13 |
| 5505 | DTI TBSS FA Superior longitudinal fasciculus R | GCST90384420 | 1.12 |
| 5506 | Nonalcoholic fatty liver disease in overweight individuals (25<=BMI<=30) | GCST90275047 | 1.12 |
| 5507 | IDP dMRI ProbtrackX MD cgc r | GCST90004224 | 1.12 |
| 5508 | Frequency of solarium/sunlamp use | Sun exposure | UKBB00000265 | 1.12 |
| 5509 | Duodenal ulcer | FING00000481 | 1.12 |
| 5510 | Autorefraction - 6mm asymmetry angle (left) | Eyesight | UKBB00000072 | 1.12 |
| 5511 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T188 | ECGA000188 | 1.12 |
| 5512 | Arm fat mass (right) | Impedance measures | UKBB00000044 | 1.12 |
| 5513 | CKAP4/LAMP3 ratio | GCST90314073 | 1.12 |
| 5514 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T493 | ECGU000493 | 1.12 |
| 5515 | CD99/PIK3IP1 ratio | GCST90313929 | 1.12 |
| 5516 | Principal component-derived dietary pattern 17 | GCST90133022 | 1.12 |
| 5517 | IDP T1 FAST ROIs R cerebellum crus I | GCST90002571 | 1.11 |
| 5518 | ADA2/VCAM1 ratio | GCST90313167 | 1.11 |
| 5519 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T57 | ECGA000057 | 1.11 |
| 5520 | RLN2 levels | GCST90470474 | 1.11 |
| 5521 | Bread type: White (UKB data field 1448_1) | GCST90132964 | 1.11 |
| 5522 | Reaction time | GCST006268 | 1.11 |
| 5523 | AIFM1/EGF ratio | GCST90313219 | 1.11 |
| 5524 | Mean corpuscular volume | GCST90018746 | 1.11 |
| 5525 | FAM13A levels | GCST90469181 | 1.11 |
| 5526 | PDGFA levels | GCST90470188 | 1.11 |
| 5527 | aparc-Desikan rh area TotalSurface | GCST90003107 | 1.11 |
| 5528 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T92 | ECGU000092 | 1.11 |
| 5529 | T1 FreeSurfer aseg 3rd-Ventricle | GCST90384147 | 1.11 |
| 5530 | HippSubfield lh volume CA4-body | GCST90002683 | 1.11 |
| 5531 | COMP/ITGAV ratio | GCST90314190 | 1.11 |
| 5532 | LGALS7_LGALS7B/WFDC12 ratio | GCST90315317 | 1.11 |
| 5533 | Acetone levels (UKB data field 23477) | GCST90269574 | 1.11 |
| 5534 | GPC1/ITGB6 ratio | GCST90314977 | 1.11 |
| 5535 | Cholelithiasis | GCST90018599 | 1.11 |
| 5536 | BA-exvivo rh thickness BA1 | GCST90003527 | 1.10 |
| 5537 | CTRC/PLA2G1B ratio | GCST90314310 | 1.10 |
| 5538 | IST1 levels | GCST90469632 | 1.10 |
| 5539 | Myocardial infarction | circulatory system | UKBB00000491 | 1.10 |
| 5540 | Takes medication for prostate cancer? | GCST90475187 | 1.10 |
| 5541 | QC T1-to-standard linear alignment discrepancy | GCST90006345 | 1.10 |
| 5542 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T315 | ECGU000315 | 1.10 |
| 5543 | Left-hemisphere visual network to left-hemisphere limbic network white-matter structural connectivity | GCST90302652 | 1.10 |
| 5544 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T122 | ECGU000122 | 1.10 |
| 5545 | PODXL2/SDC1 ratio | GCST90315701 | 1.10 |
| 5546 | Right ventricular end systolic volume | GCST90268118 | 1.10 |
| 5547 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T398 | ECGA000398 | 1.10 |
| 5548 | SIGLEC1/SSC5D ratio | GCST90315844 | 1.09 |
| 5549 | Diabetes, insulin treatment (Kela reimbursement) (more control exclusions) | FING00000410 | 1.09 |
| 5550 | AMOT levels | GCST90468295 | 1.09 |
| 5551 | Wears glasses or contact lenses | Eyesight | UKBB00000907 | 1.09 |
| 5552 | STX16 levels | GCST90470769 | 1.09 |
| 5553 | Omega-3 fatty acids to total fatty acids percentage | GCST90502449 | 1.09 |
| 5554 | Symbol digit substitution test performance (baseline) | GCST90565841 | 1.09 |
| 5555 | HNRNPUL1 levels | GCST90469470 | 1.09 |
| 5556 | DDR1/PVR ratio | GCST90314442 | 1.09 |
| 5557 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T191 | ECGU000191 | 1.09 |
| 5558 | IDP dMRI TBSS ICVF Posterior corona radiata L | GCST90004354 | 1.09 |
| 5559 | Activities undertaken to treat depression | Depression | UKBB00000010 | 1.09 |
| 5560 | Macular cyst | FING00000743 | 1.09 |
| 5561 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T172 | ECGU000172 | 1.09 |
| 5562 | 1-stearoyl-2-arachidonoyl-gpc (18:0/20:4) levels | GCST90200685 | 1.09 |
| 5563 | SARG levels | GCST90470526 | 1.09 |
| 5564 | GP5 levels | GCST90469383 | 1.09 |
| 5565 | PLA2G15/SMPDL3A ratio | GCST90315663 | 1.08 |
| 5566 | MLN/TNFRSF12A ratio | GCST90315459 | 1.08 |
| 5567 | Peripheral vascular disease, unspecified (PheCode 443.9) | GCST90475998 | 1.08 |
| 5568 | mean corpuscular hemoglobin (MCH, minimum, inv-norm transformed) | GCST90475450 | 1.08 |
| 5569 | Vegetable intake (standard GWA) | GCST90267306 | 1.08 |
| 5570 | Multiple myeloma or monoclonal gammopathy of undetermined significance | GCST90624746 | 1.08 |
| 5571 | ALCAM/CNTN1 ratio | GCST90313235 | 1.08 |
| 5572 | ENO2/SULT1A1 ratio | GCST90314669 | 1.08 |
| 5573 | MNX1 levels | GCST90090758 | 1.08 |
| 5574 | GPC5 levels | GCST90469387 | 1.08 |
| 5575 | Heart valve replaced (PheCode 395.6) | GCST90475915 | 1.08 |
| 5576 | FADD/PPP1R2 ratio | GCST90314774 | 1.08 |
| 5577 | Abdominal hernia (PheCode 550) | GCST90476059 | 1.08 |
| 5578 | FKBP1B levels | GCST90469242 | 1.08 |
| 5579 | DAAM1 levels | GCST90468941 | 1.08 |
| 5580 | IDP dMRI ProbtrackX ISOVF fma | GCST90004535 | 1.08 |
| 5581 | Heart valve disorders (PheCode 395) | GCST90475913 | 1.08 |
| 5582 | Hearing difficulty/problems: No (UKB data field 2247_0) | GCST90042881 | 1.08 |
| 5583 | LSP1 levels | GCST90469811 | 1.08 |
| 5584 | LCN2/PGLYRP1 ratio | GCST90315306 | 1.08 |
| 5585 | GP1BB levels | GCST90469381 | 1.07 |
| 5586 | MMP12 levels | GCST90469916 | 1.07 |
| 5587 | Type 1 diabetes (PheCode 250.1) | GCST90475661 | 1.07 |
| 5588 | Type 2 diabetes | GCST90086071 | 1.07 |
| 5589 | Diverticulosis and diverticulitis (PheCode 562) | GCST90476073 | 1.07 |
| 5590 | Heart rate variability traits (SDNN) | GCST004734 | 1.07 |
| 5591 | Operative procedures - Primary repair of inguinal hernia using insert of prosthetic material | Summary Operations | UKBB00000587 | 1.07 |
| 5592 | PRTFDC1 levels | GCST90470346 | 1.07 |
| 5593 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T120 | ECGU000120 | 1.07 |
| 5594 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T457 | ECGU000457 | 1.07 |
| 5595 | ADGRE2/B4GALT1 ratio | GCST90313174 | 1.07 |
| 5596 | CD84/GP1BA ratio | GCST90313913 | 1.07 |
| 5597 | Osteoporosis | GCST90086122 | 1.07 |
| 5598 | SRP14 levels | GCST90470742 | 1.06 |
| 5599 | aparc-DKTatlas rh thickness lateraloccipital | GCST90003580 | 1.06 |
| 5600 | PIK3IP1 levels | GCST90470234 | 1.06 |
| 5601 | ThalamNuclei lh volume Pf | GCST90002722 | 1.06 |
| 5602 | PCDH1/TNFRSF11A ratio | GCST90315608 | 1.06 |
| 5603 | DTI autoptx MD atr r tract | GCST90385223 | 1.06 |
| 5604 | L3HYPDH levels | GCST90469724 | 1.06 |
| 5605 | PTPRN2 levels | GCST90470385 | 1.06 |
| 5606 | TOP2B levels | GCST90470934 | 1.06 |
| 5607 | LTB4R levels | GCST90422164 | 1.06 |
| 5608 | aparc-Desikan rh thickness lingual | GCST90003491 | 1.06 |
| 5609 | Other cataract | Disorders of lens | UKBB00000602 | 1.06 |
| 5610 | NFATC1/TJAP1 ratio | GCST90315540 | 1.06 |
| 5611 | IDP T1 FAST ROIs L intracalc cortex | GCST90002497 | 1.06 |
| 5612 | DCTN1 levels | GCST90468958 | 1.06 |
| 5613 | Disorders of muscle, ligament, and fascia | musculoskeletal | UKBB00000187 | 1.06 |
| 5614 | Forced expiratory volume in 1-second (FEV1) | Spirometry | UKBB00000251 | 1.06 |
| 5615 | HGF/MMP8 ratio | GCST90315055 | 1.05 |
| 5616 | F-chocolate/coffee liking (derived food-liking factor) | GCST90094735 | 1.05 |
| 5617 | Right-hemisphere visual network to right-hemisphere control network white-matter structural connectivity | GCST90302779 | 1.05 |
| 5618 | CD79B/FCRL1 ratio | GCST90313899 | 1.05 |
| 5619 | IL1RN/LGALS9 ratio | GCST90315160 | 1.05 |
| 5620 | EFNA1 levels | GCST90469080 | 1.05 |
| 5621 | PMVK/PRDX5 ratio | GCST90315694 | 1.05 |
| 5622 | MDH1 levels | GCST90469876 | 1.05 |
| 5623 | aparc-DKTatlas lh volume postcentral | GCST90002882 | 1.05 |
| 5624 | CD80 on monocyte | GCST90002039 | 1.05 |
| 5625 | T1 CAT volume L PlanumPolare | GCST90384086 | 1.05 |
| 5626 | CREG1/SMPDL3A ratio | GCST90314252 | 1.05 |
| 5627 | CRIP2 levels | GCST90468864 | 1.05 |
| 5628 | Mineral and other dietary supplements - Fish oil (including cod liver oil) | Medication | UKBB00000472 | 1.04 |
| 5629 | TNFRSF19 levels | GCST90088947 | 1.04 |
| 5630 | Skin color (cheek, B value) | GCST90502779 | 1.04 |
| 5631 | White blood cell count | GCST90278647 | 1.04 |
| 5632 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T169 | ECGU000169 | 1.04 |
| 5633 | MCAM/NCAM1 ratio | GCST90315408 | 1.04 |
| 5634 | VNN2 levels | GCST90618510 | 1.04 |
| 5635 | Heart rate variability traits (RMSSD) | GCST004733 | 1.04 |
| 5636 | IDP dMRI TBSS ISOVF Anterior corona radiata L | GCST90004500 | 1.04 |
| 5637 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T171 | ECGU000171 | 1.04 |
| 5638 | REG1B/REG3A ratio | GCST90315765 | 1.04 |
| 5639 | DIPK2B levels | GCST90468996 | 1.04 |
| 5640 | Alzheimer's disease (MTAG) | GCST90449053 | 1.04 |
| 5641 | DTI autoptx L3 atr r tract | GCST90385196 | 1.04 |
| 5642 | Arm fat percentage left (UKB data field 23123) | GCST90468157 | 1.04 |
| 5643 | HTRA2 levels | GCST90469494 | 1.04 |
| 5644 | ANKRD54 levels | GCST90468311 | 1.03 |
| 5645 | DOK1 levels | GCST90469028 | 1.03 |
| 5646 | NAGA levels | GCST90469994 | 1.03 |
| 5647 | CCL28 levels | GCST90468580 | 1.03 |
| 5648 | LAMB1 levels | GCST90469732 | 1.03 |
| 5649 | Principal component-derived dietary pattern 30 | GCST90133035 | 1.03 |
| 5650 | aparc-DKTatlas lh volume lateraloccipital | GCST90002871 | 1.03 |
| 5651 | COL6A3/TAFA5 ratio | GCST90314180 | 1.03 |
| 5652 | TGFBR3 levels | GCST90470848 | 1.03 |
| 5653 | mean corpuscular hemoglobin (MCH, mean, inv-norm transformed) | GCST90475446 | 1.03 |
| 5654 | High-grade serous epithelial ovarian cancer | GCST90244168 | 1.03 |
| 5655 | CSNK1D levels | GCST90468888 | 1.03 |
| 5656 | IDP dMRI TBSS ICVF Posterior corona radiata R | GCST90004353 | 1.03 |
| 5657 | Corneal resistance factor | GCST90100568 | 1.02 |
| 5658 | NBL1 levels | GCST90470001 | 1.02 |
| 5659 | F-salty food liking (derived food-liking factor) | GCST90094827 | 1.02 |
| 5660 | Right ventricular ejection fraction | GCST90268117 | 1.02 |
| 5661 | Descending aorta distensibility | GCST90267386 | 1.02 |
| 5662 | Liver volume (adjusted for height) | GCST90566819 | 1.02 |
| 5663 | PRDX3 levels | GCST90470317 | 1.02 |
| 5664 | T2 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 111) | GCST90320930 | 1.02 |
| 5665 | ROR1 levels | GCST90470492 | 1.02 |
| 5666 | NT5C1A levels | GCST90470090 | 1.02 |
| 5667 | GM2A levels | GCST90469365 | 1.02 |
| 5668 | CDKN1A/YES1 ratio | GCST90313980 | 1.02 |
| 5669 | Principal component-derived dietary pattern 29 | GCST90133034 | 1.02 |
| 5670 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T479 | ECGU000479 | 1.02 |
| 5671 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T116 | ECGA000116 | 1.02 |
| 5672 | Arm predicted mass (right) | Impedance measures | UKBB00000050 | 1.02 |
| 5673 | T1 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 122) | GCST90320685 | 1.02 |
| 5674 | IDP dMRI TBSS ICVF Retrolenticular part of internal capsule L | GCST90004348 | 1.02 |
| 5675 | Water intake | Diet | UKBB00000906 | 1.02 |
| 5676 | DKK1/PTPN6 ratio | GCST90314478 | 1.01 |
| 5677 | HHIP levels | GCST90617097 | 1.01 |
| 5678 | Valine levels | GCST90500177 | 1.01 |
| 5679 | SMAD3 levels | GCST90470677 | 1.01 |
| 5680 | Other disorders of circulatory system | circulatory system | UKBB00000607 | 1.01 |
| 5681 | IDP dMRI TBSS ISOVF Sagittal stratum L | GCST90004508 | 1.01 |
| 5682 | Dried fruit intake | Diet | UKBB00000193 | 1.01 |
| 5683 | ICA1 levels | GCST90469497 | 1.01 |
| 5684 | ANGPTL3 levels | GCST90468304 | 1.01 |
| 5685 | Skin yellow/blue component | GCST90320259 | 1.01 |
| 5686 | EFNA4 levels | GCST90469081 | 1.01 |
| 5687 | SOST levels | GCST90470711 | 1.01 |
| 5688 | IDP dMRI TBSS MD Body of corpus callosum | GCST90004030 | 1.01 |
| 5689 | METAP1D levels | GCST90469892 | 1.01 |
| 5690 | Glycine levels | GCST007638 | 1.01 |
| 5691 | FHIT/PMVK ratio | GCST90314822 | 1.00 |
| 5692 | IDP dMRI TBSS L2 Body of corpus callosum | GCST90004126 | 1.00 |
| 5693 | CKAP4/LTBR ratio | GCST90314074 | 1.00 |
| 5694 | F-fish liking (derived food-liking factor) | GCST90094762 | 1.00 |
| 5695 | CST3/TIMP1 ratio | GCST90314300 | 1.00 |
| 5696 | Sodium in urine | Urine assays | UKBB00000785 | 1.00 |
| 5697 | IDP dMRI ProbtrackX FA atr r | GCST90003928 | 1.00 |
| 5698 | Takes medication for gout? | GCST90476382 | 1.00 |
| 5699 | CD22/FCER2 ratio | GCST90313756 | 1.00 |
| 5700 | Insomnia (PheCode 327.4) | GCST90475826 | 1.00 |
| 5701 | NINJ1 levels | GCST90470049 | 1.00 |
| 5702 | GRAP2/PLPBP ratio | GCST90314984 | 1.00 |
| 5703 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T80 | ECGU000080 | 1.00 |
| 5704 | Irregular menstrual cycle/bleeding | genitourinary | UKBB00000379 | 1.00 |
| 5705 | Dried fruit consumption | GCST90132980 | 0.99 |
| 5706 | COL18A1/RARRES2 ratio | GCST90314169 | 0.99 |
| 5707 | Coronary atherosclerosis | circulatory system | UKBB00000152 | 0.99 |
| 5708 | UROD levels | GCST90471016 | 0.99 |
| 5709 | ALDH1A1/CA3 ratio | GCST90313244 | 0.99 |
| 5710 | IDP dMRI ProbtrackX L2 ilf r | GCST90004288 | 0.99 |
| 5711 | Ever Smoker | FING00000522 | 0.99 |
| 5712 | Total free cholesterol levels | GCST90092988 | 0.99 |
| 5713 | LRG1 levels | GCST90469793 | 0.99 |
| 5714 | Osteoarthritis (self-reported) | GCST005811 | 0.99 |
| 5715 | Flat foot (PheCode 735.1) | GCST90476248 | 0.99 |
| 5716 | CLEC4M levels | GCST90468775 | 0.99 |
| 5717 | Acquired foot deformities | musculoskeletal | UKBB00000007 | 0.99 |
| 5718 | FOXO1/USP8 ratio | GCST90314879 | 0.99 |
| 5719 | Prevotellamassilia abundance in stool | GCST90032517 | 0.99 |
| 5720 | Polycystic ovarian syndrome, broad definition | FING00001183 | 0.99 |
| 5721 | SDC4/WWP2 ratio | GCST90315821 | 0.99 |
| 5722 | Leucine levels (UKB data field 23466) | GCST90269563 | 0.99 |
| 5723 | Spread type - Other type of spread/margarine | Diet | UKBB00000795 | 0.99 |
| 5724 | aparc-a2009s rh area S-subparietal | GCST90003441 | 0.98 |
| 5725 | CD163/ICAM1 ratio | GCST90313735 | 0.98 |
| 5726 | SMNDC1 levels | GCST90470681 | 0.98 |
| 5727 | CDH17 levels | GCST90468669 | 0.98 |
| 5728 | Right ventricular stroke volume | GCST90268122 | 0.98 |
| 5729 | WWP2 levels | GCST90471080 | 0.98 |
| 5730 | Asthma | GCST006862 | 0.98 |
| 5731 | IDP dMRI TBSS ISOVF Superior longitudinal fasciculus L | GCST90004518 | 0.98 |
| 5732 | Direct low density lipoprotein levels (UKB data field 30780) | GCST90468080 | 0.98 |
| 5733 | Adenocarcinoma, papilloma adenocarcinoma and mucinous carcinomas of rectum, excluding all cancers (controls excluding all cancers) | FING00000041 | 0.98 |
| 5734 | Phosphatidylcholine (18:0_20:3) levels | GCST90024876 | 0.98 |
| 5735 | CD22/CD79B ratio | GCST90313755 | 0.98 |
| 5736 | TREH levels | GCST90470959 | 0.98 |
| 5737 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T458 | ECGU000458 | 0.98 |
| 5738 | EIF4G1/MAVS ratio | GCST90314636 | 0.98 |
| 5739 | MCEMP1 levels | GCST90469872 | 0.98 |
| 5740 | Right-hemisphere default mode network to thalamus white-matter structural connectivity | GCST90302844 | 0.98 |
| 5741 | Total cholesterol minus HDL-C levels | GCST90092930 | 0.98 |
| 5742 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T298 | ECGU000298 | 0.98 |
| 5743 | FXN levels | GCST90469282 | 0.97 |
| 5744 | Duration to first press of snap-button in each round | Reaction time | UKBB00000202 | 0.97 |
| 5745 | Testosterone | Blood biochemistry | UKBB00000816 | 0.97 |
| 5746 | Mean sphered cell volume | Blood count | UKBB00000452 | 0.97 |
| 5747 | SERPINB13 levels | GCST90423326 | 0.97 |
| 5748 | QC T1-to-standard nonlinear alignment discrepancy | GCST90006346 | 0.97 |
| 5749 | FLT3LG levels | GCST90469250 | 0.97 |
| 5750 | Staphylococcus A fleurettii abundance in stool | GCST90032564 | 0.97 |
| 5751 | Left ventricular end diastolic volume (indexed to body surface area) | GCST90435258 | 0.97 |
| 5752 | IGF1 levels | GCST90102623 | 0.97 |
| 5753 | RAB27B levels | GCST90470405 | 0.97 |
| 5754 | PCDH7 levels | GCST90470171 | 0.97 |
| 5755 | TBC1D5 levels | GCST90470811 | 0.97 |
| 5756 | Docosahexaenoic acid levels | GCST90502259 | 0.97 |
| 5757 | CLEC1B/SNAP29 ratio | GCST90314103 | 0.97 |
| 5758 | ADA2/COMP ratio | GCST90313166 | 0.97 |
| 5759 | TPMT levels | GCST90470945 | 0.97 |
| 5760 | CPXM1/HBEGF ratio | GCST90314219 | 0.97 |
| 5761 | Dementia | FING00000391 | 0.96 |
| 5762 | SNAP29/SNX9 ratio | GCST90315859 | 0.96 |
| 5763 | IDP dMRI ProbtrackX ICVF unc r | GCST90004401 | 0.96 |
| 5764 | FAM3B/GUCA2A ratio | GCST90314779 | 0.96 |
| 5765 | IDP T1 FAST ROIs L cerebellum VI | GCST90002566 | 0.96 |
| 5766 | DBNL/VASH1 ratio | GCST90314427 | 0.96 |
| 5767 | Clinical LDL cholesterol levels | GCST90497219 | 0.96 |
| 5768 | DCTD levels | GCST90468957 | 0.96 |
| 5769 | Educational attainment (confirmatory factor analysis Factor 10) | GCST90309344 | 0.96 |
| 5770 | Extrapyramidal disease and abnormal movement disorders (PheCode 333) | GCST90475831 | 0.96 |
| 5771 | AGRP levels | GCST90240217 | 0.96 |
| 5772 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T79 | ECGA000079 | 0.96 |
| 5773 | KCTD5 levels | GCST90469670 | 0.96 |
| 5774 | Principal component-derived dietary pattern 16 | GCST90133021 | 0.96 |
| 5775 | MED18 levels | GCST90469880 | 0.95 |
| 5776 | IPCEF1/SMAD1 ratio | GCST90315185 | 0.95 |
| 5777 | aparc-Desikan rh volume postcentral | GCST90002822 | 0.95 |
| 5778 | DOK2/FADD ratio | GCST90314530 | 0.95 |
| 5779 | HPCAL1/SERPINB9 ratio | GCST90315079 | 0.95 |
| 5780 | BMP6 levels | GCST90468454 | 0.95 |
| 5781 | T1 CAT volume L VIIIb | GCST90384130 | 0.95 |
| 5782 | HEXIM1/TBL1X ratio | GCST90315053 | 0.95 |
| 5783 | Coronary artery plaque burden | GCST90503075 | 0.95 |
| 5784 | DTI autoptx L1 atr r tract | GCST90385142 | 0.95 |
| 5785 | Age at first sexual intercourse | GCST90000047 | 0.95 |
| 5786 | Acute osteomyelitis (PheCode 710.11) | GCST90476222 | 0.95 |
| 5787 | DLG4 levels | GCST90469001 | 0.95 |
| 5788 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T280 | ECGU000280 | 0.95 |
| 5789 | Holdemania abundance in stool | GCST90032432 | 0.94 |
| 5790 | T1 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 83) | GCST90320646 | 0.94 |
| 5791 | aparc-Desikan lh volume postcentral | GCST90002789 | 0.94 |
| 5792 | Erythronate levels | GCST90243696 | 0.94 |
| 5793 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T190 | ECGU000190 | 0.94 |
| 5794 | AKT1S1/FHIT ratio | GCST90313228 | 0.94 |
| 5795 | Disorders of eyelid, lacrimal system and orbit | FING00000439 | 0.94 |
| 5796 | APP/PPP1R12A ratio | GCST90313330 | 0.94 |
| 5797 | OGA levels | GCST90470117 | 0.94 |
| 5798 | C1QTNF5 levels | GCST90468489 | 0.94 |
| 5799 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T95 | ECGA000095 | 0.94 |
| 5800 | FABP2/LGALS4 ratio | GCST90314756 | 0.94 |
| 5801 | THY1/TNFRSF21 ratio | GCST90315919 | 0.94 |
| 5802 | Occupation and workplace environment (confirmatory factor analysis Factor 5) | GCST90309340 | 0.94 |
| 5803 | IDP dMRI TBSS L3 Genu of corpus callosum | GCST90004173 | 0.94 |
| 5804 | Pain type(s) experienced in last month - Stomach or abdominal pain | Pain | UKBB00000633 | 0.94 |
| 5805 | Oral glucose tolerance test-0h | GCST90566421 | 0.94 |
| 5806 | Chronic airway obstruction (PheCode 496) | GCST90476027 | 0.94 |
| 5807 | IDP dMRI TBSS MD Anterior corona radiata L | GCST90004050 | 0.93 |
| 5808 | BCR/DECR1 ratio | GCST90313489 | 0.93 |
| 5809 | 1,2-dipalmitoyl-GPC (16:0/16:0) metabolite level | GCST90615438 | 0.93 |
| 5810 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T170 | ECGU000170 | 0.93 |
| 5811 | Haemorrhoids and perianal venous thrombosis | FING00000599 | 0.93 |
| 5812 | ROR1/THBD ratio | GCST90315786 | 0.93 |
| 5813 | TTN levels | GCST90470984 | 0.93 |
| 5814 | Left-hemisphere somatomotor network to left-hemisphere control network white-matter structural connectivity | GCST90302673 | 0.93 |
| 5815 | CD36 levels | GCST90468627 | 0.93 |
| 5816 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T325 | ECGU000325 | 0.93 |
| 5817 | PLXNB2 levels | GCST90242299 | 0.93 |
| 5818 | White blood cell count | GCST90018758 | 0.92 |
| 5819 | ECG, load | ECG during exercise | UKBB00000205 | 0.92 |
| 5820 | IDP dMRI TBSS FA Superior fronto-occipital fasciculus L | GCST90003920 | 0.92 |
| 5821 | LRP11 levels | GCST90469796 | 0.92 |
| 5822 | DSG4 levels | GCST90469044 | 0.92 |
| 5823 | AmygNuclei rh volume Whole-amygdala | GCST90002667 | 0.92 |
| 5824 | Phosphatidylethanolamine (38:4) levels | GCST90488261 | 0.92 |
| 5825 | Principal component-derived dietary pattern 33 | GCST90133038 | 0.92 |
| 5826 | Omega-3 fatty acid levels | GCST90502422 | 0.92 |
| 5827 | Lysoalkylphosphatidylcholine (O-24:1) levels | GCST90024198 | 0.92 |
| 5828 | COCH levels | GCST90468810 | 0.92 |
| 5829 | SPINK2 levels | GCST90470722 | 0.92 |
| 5830 | F-salad vegetables liking (derived food-liking factor) | GCST90094824 | 0.92 |
| 5831 | Blood glucose levels | GCST90025986 | 0.92 |
| 5832 | S100A4/SNAP29 ratio | GCST90315801 | 0.92 |
| 5833 | heart rate (HR, mean, inv-normal transformed) | GCST90476338 | 0.92 |
| 5834 | MECR levels | GCST90469879 | 0.92 |
| 5835 | Spherical power (left) | Autorefraction | UKBB00000790 | 0.92 |
| 5836 | DTI TBSS L2 Tapetum L | GCST90384523 | 0.92 |
| 5837 | Androstenediol (3beta,17beta) disulfate (2) levels | GCST90199851 | 0.91 |
| 5838 | aseg global volume 4th-Ventricle | GCST90002600 | 0.91 |
| 5839 | GSN levels | GCST90469409 | 0.91 |
| 5840 | Age when finished full-time education (standard GWA) | GCST90267280 | 0.91 |
| 5841 | Mean corpuscular haemoglobin (UKB data field 30050) | GCST90468084 | 0.91 |
| 5842 | CFP levels | GCST90468731 | 0.91 |
| 5843 | aparc-DKTatlas rh volume postcentral | GCST90002913 | 0.91 |
| 5844 | aparc-DKTatlas rh thickness lingual | GCST90003582 | 0.91 |
| 5845 | Processed meat intake | Diet | UKBB00000711 | 0.91 |
| 5846 | CSPG4 levels | GCST90468890 | 0.91 |
| 5847 | Body mass index | GCST90025994 | 0.91 |
| 5848 | IDP dMRI TBSS L1 Superior longitudinal fasciculus L | GCST90004116 | 0.91 |
| 5849 | Hippocampal subfield left CA3 volume (head) | GCST90267941 | 0.91 |
| 5850 | MCEE levels | GCST90469871 | 0.91 |
| 5851 | GASK1A levels | GCST90469306 | 0.91 |
| 5852 | IDP dMRI TBSS L2 Superior fronto-occipital fasciculus L | GCST90004166 | 0.91 |
| 5853 | Chronic pancreatitis | GCST90018601 | 0.90 |
| 5854 | NBL1/NECTIN4 ratio | GCST90315514 | 0.90 |
| 5855 | IDP dMRI ProbtrackX FA ilf r | GCST90003940 | 0.90 |
| 5856 | Left-hemisphere dorsal attention network to right-hemisphere visual network white-matter structural connectivity | GCST90302694 | 0.90 |
| 5857 | FABP4 levels | GCST90469176 | 0.90 |
| 5858 | IDP T1 FAST ROIs R cerebellum VIIIb | GCST90002583 | 0.90 |
| 5859 | MAX levels | GCST90469867 | 0.90 |
| 5860 | IDP dMRI TBSS OD Superior fronto-occipital fasciculus R | GCST90004444 | 0.90 |
| 5861 | PIK3IP1/TNFRSF1B ratio | GCST90315654 | 0.90 |
| 5862 | CXCL11 levels | GCST90468924 | 0.90 |
| 5863 | Medication for pain relief, constipation, heartburn - Laxatives (e.g. Dulcolax, Senokot) | Medication | UKBB00000456 | 0.90 |
| 5864 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T318 | ECGA000318 | 0.90 |
| 5865 | DLK1 levels | GCST90469003 | 0.90 |
| 5866 | Adenocarcinoma and papilloma adenocarcinoma of rectum | FING00000039 | 0.90 |
| 5867 | EGF/GP6 ratio | GCST90314608 | 0.90 |
| 5868 | Bread type - White | Diet | UKBB00000106 | 0.90 |
| 5869 | DAB2/VASH1 ratio | GCST90314369 | 0.90 |
| 5870 | Lymphoid neoplasms (somatic mutation group 2 phenocluster) | GCST90624750 | 0.90 |
| 5871 | LBR/MAD1L1 ratio | GCST90315295 | 0.90 |
| 5872 | Cirrhosis, broad definition used in the article https://doi.org/10.1101/594523 | FING00000304 | 0.90 |
| 5873 | Facial pigmentation measurement (polar light) | GCST90002284 | 0.90 |
| 5874 | CRTAM/VCAM1 ratio | GCST90314281 | 0.90 |
| 5875 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T189 | ECGA000189 | 0.89 |
| 5876 | RAB2B levels | GCST90470406 | 0.89 |
| 5877 | PTGR1 levels | GCST90470370 | 0.89 |
| 5878 | Mean carotid IMT (intima-medial thickness) at 240 degrees | Carotid ultrasound | UKBB00000446 | 0.89 |
| 5879 | Omega-3 fatty acid levels | GCST90502055 | 0.89 |
| 5880 | NSFL1C/PSMG3 ratio | GCST90315559 | 0.89 |
| 5881 | MICB_MICA/TEK ratio | GCST90315446 | 0.89 |
| 5882 | PON2 levels | GCST90470286 | 0.89 |
| 5883 | Cardiomyopathy | FING00000250 | 0.89 |
| 5884 | CIAPIN1/SNAP29 ratio | GCST90314067 | 0.89 |
| 5885 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T193 | ECGA000193 | 0.89 |
| 5886 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T122 | ECGA000122 | 0.88 |
| 5887 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T1 | ECGA000001 | 0.88 |
| 5888 | IDP dMRI ProbtrackX ICVF fmi | GCST90004386 | 0.88 |
| 5889 | B4GALT1/SPON2 ratio | GCST90313434 | 0.88 |
| 5890 | (R)-3-hydroxybutyrylcarnitine levels | GCST90199930 | 0.88 |
| 5891 | Alcohol consumption | GCST90133003 | 0.88 |
| 5892 | CCN2/TPP1 ratio | GCST90313718 | 0.88 |
| 5893 | HSPG2/SMOC2 ratio | GCST90315093 | 0.88 |
| 5894 | IGFBP1 levels | GCST90469527 | 0.88 |
| 5895 | ANPEP/DPP4 ratio | GCST90313273 | 0.88 |
| 5896 | CCL17/CCL22 ratio | GCST90313682 | 0.88 |
| 5897 | MITD1 levels | GCST90469910 | 0.88 |
| 5898 | HPCAL1/PMVK ratio | GCST90315076 | 0.88 |
| 5899 | FCGR2A levels | GCST90469200 | 0.87 |
| 5900 | MAP2K1 levels | GCST90469851 | 0.87 |
| 5901 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T156 | ECGU000156 | 0.87 |
| 5902 | Prescriptions - biguanides|diabetes | UKBB00000671 | 0.87 |
| 5903 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T190 | ECGA000190 | 0.87 |
| 5904 | BIRC2 levels | GCST90468446 | 0.87 |
| 5905 | IDP dMRI TBSS FA Superior corona radiata R | GCST90003901 | 0.87 |
| 5906 | Prescriptions - metformin | biguanides,diabetes | UKBB00000692 | 0.87 |
| 5907 | Urine N1,N12-diacetylspermine levels in chronic kidney disease | GCST90265683 | 0.87 |
| 5908 | Early onset COPD | FING00000485 | 0.87 |
| 5909 | DTI TBSS FA Posterior thalamic radiation R | GCST90384408 | 0.87 |
| 5910 | CRYBB1 levels | GCST90468874 | 0.87 |
| 5911 | Polyunsaturated fatty acids to monounsaturated fatty acids ratio | GCST90502155 | 0.87 |
| 5912 | SF3B4/SIRT2 ratio | GCST90315838 | 0.87 |
| 5913 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T331 | ECGU000331 | 0.87 |
| 5914 | Impedance of arm left (UKB data field 23110) | GCST90468171 | 0.86 |
| 5915 | Salmon liking | GCST90094826 | 0.86 |
| 5916 | FURIN/PLA2G15 ratio | GCST90314887 | 0.86 |
| 5917 | Trunk fat-free mass | Impedance measures | UKBB00000865 | 0.86 |
| 5918 | SCARF2/TNFRSF21 ratio | GCST90315813 | 0.86 |
| 5919 | Stearoylcarnitine (C18) levels | GCST90199743 | 0.86 |
| 5920 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T115 | ECGA000115 | 0.86 |
| 5921 | CERT levels | GCST90468717 | 0.86 |
| 5922 | CDKN2D levels | GCST90468685 | 0.86 |
| 5923 | AGXT/GSTA1 ratio | GCST90313206 | 0.86 |
| 5924 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T461 | ECGU000461 | 0.86 |
| 5925 | Valine levels | GCST90092995 | 0.86 |
| 5926 | RBFOX3 levels | GCST90470432 | 0.86 |
| 5927 | X-21736 levels | GCST90200584 | 0.86 |
| 5928 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T227 | ECGA000227 | 0.85 |
| 5929 | Total lipids in large LDL | GCST90498011 | 0.85 |
| 5930 | CDH1 levels | GCST90468670 | 0.85 |
| 5931 | LAT/SERPINE1 ratio | GCST90315287 | 0.85 |
| 5932 | CDH3/TNFRSF21 ratio | GCST90313953 | 0.85 |
| 5933 | Heart attack | GCST90475211 | 0.85 |
| 5934 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T456 | ECGU000456 | 0.85 |
| 5935 | Retrobulbar neuritis in diseases classified elsewhere | FING00001265 | 0.85 |
| 5936 | Irritable bowel syndrome mixed subtype | GCST90243959 | 0.85 |
| 5937 | Pulse wave peak to peak time | Arterial stiffness | UKBB00000725 | 0.85 |
| 5938 | Benign neoplasm of other and unspecified endocrine glands | FING00000159 | 0.85 |
| 5939 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T399 | ECGA000399 | 0.85 |
| 5940 | wg lh intensity-contrast middletemporal | GCST90003806 | 0.85 |
| 5941 | N-acetylglycine levels | GCST90243561 | 0.85 |
| 5942 | Whole body fat mass (UKB data field 23100) | GCST90428121 | 0.85 |
| 5943 | Ganglion and cyst of synovium, tendon, and bursa (PheCode 727.4) | GCST90476243 | 0.84 |
| 5944 | aparc-Desikan rh thickness lateraloccipital | GCST90003489 | 0.84 |
| 5945 | Excessive sweating | GCST006090 | 0.84 |
| 5946 | Homeostasis model assessment of beta-cell function | GCST005180 | 0.84 |
| 5947 | TF levels | GCST90470841 | 0.84 |
| 5948 | Chest pain or discomfort | Chest pain | UKBB00000128 | 0.84 |
| 5949 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T56 | ECGA000056 | 0.84 |
| 5950 | DNAJB6 levels | GCST90469014 | 0.84 |
| 5951 | IFNGR1/THBD ratio | GCST90315130 | 0.84 |
| 5952 | Chronic dermatitis due to solar radiation (PheCode 938.2) | GCST90476288 | 0.84 |
| 5953 | Gestational diabetes (for exclusion) | FING00000573 | 0.83 |
| 5954 | RILPL2 levels | GCST90470470 | 0.83 |
| 5955 | aparc-DKTatlas rh thickness cuneus | GCST90003574 | 0.83 |
| 5956 | TIA1 levels | GCST90470862 | 0.83 |
| 5957 | height (minimum, inv-normal transformed) | GCST90475365 | 0.83 |
| 5958 | CRIM1 levels | GCST90468863 | 0.83 |
| 5959 | BA-exvivo rh thickness BA4a | GCST90003531 | 0.83 |
| 5960 | Frequency of friend/family visits | Social support | UKBB00000262 | 0.83 |
| 5961 | T1 FreeSurfer BA rh BA3a exvivo thickness | GCST90385563 | 0.83 |
| 5962 | Aortic aneurysm | FING00000102 | 0.83 |
| 5963 | Diacylglycerol_36:1_[M+H-H2O]1+ levels | GCST90060193 | 0.83 |
| 5964 | EFNA4/TNFRSF9 ratio | GCST90314606 | 0.83 |
| 5965 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T232 | ECGU000232 | 0.83 |
| 5966 | aseg rh volume VentralDC | GCST90002644 | 0.83 |
| 5967 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T168 | ECGU000168 | 0.83 |
| 5968 | PFKFB2 levels | GCST90470215 | 0.83 |
| 5969 | TPD52L2 levels | GCST90470942 | 0.83 |
| 5970 | Omega-3 fatty acids to Omega-6 fatty acids ratio | GCST90502414 | 0.82 |
| 5971 | IDP dMRI TBSS MD Cerebral peduncle L | GCST90004042 | 0.82 |
| 5972 | CDKN1A/HBEGF ratio | GCST90313972 | 0.82 |
| 5973 | Phenylalanine levels | GCST90092936 | 0.82 |
| 5974 | HHEX levels | GCST90469451 | 0.82 |
| 5975 | IDP T1 FIRST left pallidum volume | GCST90002442 | 0.82 |
| 5976 | FOLR2/MSR1 ratio | GCST90314866 | 0.82 |
| 5977 | Non-cancer illness code, self-reported - depression | Medical conditions | UKBB00000507 | 0.82 |
| 5978 | VSTM2B levels | GCST90471056 | 0.82 |
| 5979 | IDP dMRI ProbtrackX ISOVF cgc r | GCST90004530 | 0.82 |
| 5980 | ZNRD2 levels | GCST90471103 | 0.82 |
| 5981 | aparc-a2009s rh area G+S-subcentral | GCST90003374 | 0.82 |
| 5982 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T447 | ECGU000447 | 0.82 |
| 5983 | Honey liking | GCST90094782 | 0.82 |
| 5984 | hemoglobin (maximum, inv-norm transformed) | GCST90475372 | 0.82 |
| 5985 | Soy sauce liking | GCST90094844 | 0.82 |
| 5986 | CD86 levels | GCST90468654 | 0.82 |
| 5987 | LONP1 levels | GCST90469785 | 0.82 |
| 5988 | Sphingomyelin (d18:1/14:0) levels/Sphingomyelin (d16:1/16:0) levels | GCST90025743 | 0.82 |
| 5989 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T427 | ECGU000427 | 0.82 |
| 5990 | Reason for reducing amount of alcohol drunk - Health precaution | Alcohol | UKBB00000734 | 0.82 |
| 5991 | Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperium or nerve system disorders (more control exclusions) | FING00000101 | 0.82 |
| 5992 | CSF2RB levels | GCST90468883 | 0.81 |
| 5993 | C1QTNF9 levels | GCST90468491 | 0.81 |
| 5994 | Heel broadband ultrasound attenuation (left) | Bone-densitometry of heel | UKBB00000319 | 0.81 |
| 5995 | AHNAK2 levels | GCST90468260 | 0.81 |
| 5996 | PLXNA4 levels | GCST90470265 | 0.81 |
| 5997 | Coronary artery / coronary heart disease (including heart attack, angina) | GCST90475198 | 0.81 |
| 5998 | DTI TBSS L2 Superior cerebellar peduncle R | GCST90384488 | 0.81 |
| 5999 | DBN1 levels | GCST90468950 | 0.81 |
| 6000 | Secondary hypertension | FING00001285 | 0.80 |